ADDvise receives frame agreement from SLL at an order value of 20 + 20 MSEK
IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement for laparoscopy products from the County Council of Stockholm. The estimated value of the agreement for IM-Medico is 10 MSEK per annum. The agreement runs for two years with a two-year prolongation option.
IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement from the County Council of Stockholm for laparoscopy products. These products are used in laparoscopy procedures with internal stapling for invasive surgery. IM-Medico has been chosen as the preferred supplier in competition with vendors such as Johnsson & Johnsson and Medtronic.
- Rikard Akhtarzand comments the business; “Our extensive investment in the surgery segment is now paying off. To be chosen as the preferred supplier in competition with Johnsson & Johnsson and Medtronic is a major achievement for us”.
The agreement has a standstill period until January 19 2017 and starts running on June 1 2017.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 10, 2017 at 08
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com .